Cambridge Investment Research Advisors
MED icon

Cambridge Investment Research Advisors’s Medifast MED Stock Holding History

Cambridge Investment Research Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,311
Closed -$213K – 3220
2023
Q2 		$213K Sell
2,311
-99
-4% -$8.81K ﹤0.01% 2822
2023
Q1 		$250K Buy
+2,410
New +$267K ﹤0.01% 2643
2022
Q4 		– Sell
-2,607
Closed -$283K – 3170
2022
Q3 		$283K Buy
2,607
+305
+13% +$43.7K ﹤0.01% 2409
2022
Q2 		$416K Buy
2,302
+814
+55% +$146K ﹤0.01% 2104
2022
Q1 		$254K Buy
1,488
+64
+4% +$12.1K ﹤0.01% 2681
2021
Q4 		$298K Sell
1,424
-232
-14% -$48K ﹤0.01% 2532
2021
Q3 		$319K Buy
1,656
+329
+25% +$80.9K ﹤0.01% 2408
2021
Q2 		$375K Buy
1,327
+83
+7% +$22.5K ﹤0.01% 2291
2021
Q1 		$263K Buy
1,244
+83
+7% +$19.9K ﹤0.01% 2381
2020
Q4 		$228K Buy
+1,161
New +$205K ﹤0.01% 2373
2020
Q1 		– Sell
-6,611
Closed -$724K – 2405
2019
Q4 		$724K Buy
6,611
+33
+0.5% +$3.19K 0.01% 1343
2019
Q3 		$682K Sell
6,578
-182
-3% -$19.6K 0.01% 1298
2019
Q2 		$867K Buy
6,760
+108
+2% +$15K 0.01% 1101
2019
Q1 		$848K Sell
6,652
-443
-6% -$56.2K 0.01% 1124
2018
Q4 		$887K Sell
7,095
-854
-11% -$146K 0.01% 1000
2018
Q3 		$1.76M Buy
7,949
+122
+2% +$24.7K 0.02% 738
2018
Q2 		$1.25M Buy
7,827
+319
+4% +$40.8K 0.01% 866
2018
Q1 		$702K Buy
7,508
+1,701
+29% +$127K 0.01% 1136
2017
Q4 		$405K Sell
5,807
-106
-2% -$7.03K ﹤0.01% 1444
2017
Q3 		$351K Buy
5,913
+741
+14% +$36.9K ﹤0.01% 1466
2017
Q2 		$214K Sell
5,172
-1
-0% -$43 ﹤0.01% 1713
2017
Q1 		$230K Buy
5,173
+91
+2% +$3.92K ﹤0.01% 1541
2016
Q4 		$212K Buy
+5,082
New +$205K ﹤0.01% 1471

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cambridge Investment Research Advisors's MED Position: Q3 2023 in Review

Cambridge Investment Research Advisors sold out of Medifast (MED) in Q3 2023, closing a stake of 2,311 shares — an estimated $213K sold.

Cambridge Investment Research Advisors first reported a position in MED in Q4 2016 and held it in 23 quarters. The position peaked at $1.76M in Q3 2018. 223 funds tracked by Wall St. Rank hold MED as of Q3 2023.

  • Cambridge Investment Research Advisors reported no remaining Medifast position as of Q3 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 2,311 Medifast shares in Q3 2023, an estimated $213K.
  • Cambridge Investment Research Advisors first reported a position in Medifast in Q4 2016 and held it in 23 quarters.
  • Cambridge Investment Research Advisors's Medifast position peaked at $1.76M in Q3 2018.
  • 223 funds tracked by Wall St. Rank held Medifast as of Q3 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.